CD14hiHLA-DRdim macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa in Crohn's disease

Journal of Leukocyte Biology

Volumn 95, Issue 3, 2014, Pages 531-541

  Thiesen, Susanne ^a,b   Janciauskiene, Sabina ^c   Uronen Hansson, Heli ^d   Agace, William ^d   Högerkorp, Carl Magnus ^a   Spee, Pieter ^a   Håkansson, Katarina ^a   Grip, Olof ^b  

^a NOVO NORDISK A S   (Denmark)

^b LUND UNIVERSITY   (Sweden)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d LUND UNIVERSITY   (Sweden)

Author keywords

Cytokines; Inflammation; Matrix metalloproteinases; Myeloid cells

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD33 ANTIGEN; CD40 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CX3CR1; GELATINASE B; HLA DR ANTIGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; L SELECTIN; CYTOKINE; DIFFERENTIATION ANTIGEN; MATRIX METALLOPROTEINASE;

ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE RELEASE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INFLAMMATORY CELL; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADOLESCENT; BIOSYNTHESIS; BLOOD; BONE MARROW CELL; IMMUNOLOGY; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; MIDDLE AGED; PATHOLOGY; YOUNG ADULT;

CYTOKINES; INFLAMMATION; MATRIX METALLOPROTEINASES; MYELOID CELLS;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD14; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CROHN DISEASE; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; INTESTINAL MUCOSA; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; YOUNG ADULT;

EID: 84899471444     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0113021     Document Type: Article

References (50)

1. Xavier, R. J., Podolsky, D. K. (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434.
2. Hibi, T., Ogata, H. (2006) Novel pathophysiological concepts of inflammatory bowel disease. J. Gastroenterol. 41, 10-16.
3. Kamada, N., Hisamatsu, T., Okamoto, S., Chinen, H., Kobayashi, T., Sato, T., Sakuraba, A., Kitazume, M. T., Sugita, A., Koganei, K., et al. (2008) Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-γ axis. J. Clin. Invest. 118, 2269-2280.
4. Mowat, A. M., Bain, C. C. (2011) Mucosal macrophages in intestinal homeostasis and inflammation. J. Innate Immun. 3, 550-564.
5. Tamoutounour, S., Henri, S., Lelouard, H., de Bovis, B., de Haar, C., van der Woude, C. J., Woltman, A. M., Reyal, Y., Bonnet, D., Sichien, D., et al. (2012) CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur. J. Immunol. 42, 3150-3166.
6. Ziegler-Heitbrock, L., Ancuta, P., Crowe, S., Dalod, M., Grau, V., Hart, D. N., Leenen, P. J., Liu, Y. J., MacPherson, G., Randolph, G. J., et al. (2010) Nomenclature of monocytes and dendritic cells in blood. Blood 116, e74-e80.
7. Dobrovolskaia, M. A., Vogel, S. N. (2002) Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 4, 903-914.
8. Lisi, S., Sisto, M., Lofrumento, D. D., D'Amore, S., D'Amore, M. (2011) Advances in the understanding of the Fc γ receptors-mediated autoantibodies uptake. Clin. Exp. Med. 11, 1-10.
9. Cros, J., Cagnard, N., Woollard, K., Patey, N., Zhang, S. Y., Senechal, B., Puel, A., Biswas, S. K., Moshous, D., Picard, C., et al. (2010) Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity 33, 375-386.
10. Rossol, M., Kraus, S., Pierer, M., Baerwald, C., Wagner, U. (2012) The CD14(bright) CD16+ monocyte subset is expanded in rheumatoid arthritis and promotes expansion of the Th17 cell population. Arthritis Rheum. 64, 671-677.
11. Wong, K. L., Tai, J. J., Wong, W. C., Han, H., Sem, X., Yeap, W. H., Kourilsky, P., Wong, S. C. (2011) Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets. Blood 118, e16-e31.
12. Woollard, K. J., Geissmann, F. (2010) Monocytes in atherosclerosis: subsets and functions. Nat. Rev. Cardiol. 7, 77-86.
13. Grip, O., Bredberg, A., Lindgren, S., Henriksson, G. (2007) Increased subpopulations of CD16(+) and CD56(+) blood monocytes in patients with active Crohn's disease. Inflamm. Bowel Dis. 13, 566-572.
14. Zawada, A. M., Rogacev, K. S., Rotter, B., Winter, P., Marell, R. R., Fliser, D., Heine, G. H. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118, e50-e61.
15. Lee, S. H., Starkey, P. M., Gordon, S. (1985) Quantitative analysis of total macrophage content in adult mouse tissues. Immunochemical studies with monoclonal antibody F4/80. J. Exp. Med. 161, 475-489.
16. Smythies, L. E., Shen, R., Bimczok, D., Novak, L., Clements, R. H., Eckhoff, D. E., Bouchard, P., George, M. D., Hu, W. K., Dandekar, S., et al. (2010) Inflammation anergy in human intestinal macrophages is due to Smad-induced IκBα expression and NF-κB inactivation. J. Biol. Chem. 285, 19593-19604.
17. Smith, P. D., Smythies, L. E., Mosteller-Barnum, M., Sibley, D. A., Russell, M. W., Merger, M., Sellers, M. T., Orenstein, J. M., Shimada, T., Graham, M. F., et al. (2001) Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS-and IgA-mediated activities. J. Immunol. 167, 2651-2656.
18. Rogler, G., Andus, T., Aschenbrenner, E., Vogl, D., Falk, W., Scholmerich, J., Gross, V. (1997) Alterations of the phenotype of colonic macrophages in inflammatory bowel disease. Eur. J. Gastroenterol. Hepatol. 9, 893-899.
19. Koch, S., Kucharzik, T., Heidemann, J., Nusrat, A., Luegering, A. (2010) Investigating the role of proinflammatory CD16+ monocytes in the pathogenesis of inflammatory bowel disease. Clin. Exp. Immunol. 161, 332-341.
20. Bain, C. C., Mowat, A. M. (2011) Intestinal macrophages-specialised adaptation to a unique environment. Eur. J. Immunol. 41, 2494-2498.
21. Weber, B., Saurer, L., Schenk, M., Dickgreber, N., Mueller, C. (2011) CX3CR1 defines functionally distinct intestinal mononuclear phagocyte subsets which maintain their respective functions during homeostatic and inflammatory conditions. Eur. J. Immunol. 41, 773-779.
22. Platt, A. M., Bain, C. C., Bordon, Y., Sester, D. P., Mowat, A. M. (2010) An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation. J. Immunol. 184, 6843-6854.
23. Zigmond, E., Varol, C., Farache, J., Elmaliah, E., Satpathy, A. T., Friedlander, G., Mack, M., Shpigel, N., Boneca, I. G., Murphy, K. M., et al. (2012) Ly6C hi monocytes in the inflamed colon give rise to proinflammatory effector cells and migratory antigen-presenting cells. Immunity 37, 1076-1090.
24. Varol, C., Vallon-Eberhard, A., Elinav, E., Aychek, T., Shapira, Y., Luche, H., Fehling, H. J., Hardt, W. D., Shakhar, G., Jung, S. (2009) Intestinal lamina propria dendritic cell subsets have different origin and functions. Immunity 31, 502-512.
25. Rivollier, A., He, J., Kole, A., Valatas, V., Kelsall, B. L. (2012) Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J. Exp. Med. 209, 139-155.
26. Bain, C. C., Scott, C. L., Uronen-Hansson, H., Gudjonsson, S., Jansson, O., Grip, O., Guilliams, M., Malissen, B., Agace, W. W., Mowat, A. M. (2013) Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C(hi) monocyte precursors. Mucosal Immunol. 6, 498-510.
27. Grimm, M. C., Pullman, W. E., Bennett, G. M., Sullivan, P. J., Pavli, P., Doe, W. F. (1995) Direct evidence of monocyte recruitment to inflammatory bowel disease mucosa. J. Gastroenterol. Hepatol. 10, 387-395.
28. Heimbeck, I., Hofer, T. P., Eder, C., Wright, A. K., Frankenberger, M., Marei, A., Boghdadi, G., Scherberich, J., Ziegler-Heitbrock, L. (2010) Standardized single-platform assay for human monocyte subpopulations: lower CD14+CD16++ monocytes in females. Cytometry A 77, 823-830.
29. Nishimura, M., Kuboi, Y., Muramoto, K., Kawano, T., Imai, T. (2009) Chemokines as novel therapeutic targets for inflammatory bowel disease. Ann. N. Y. Acad. Sci. 1173, 350-356.
30. Ravi, A., Garg, P., Sitaraman, S. V. (2007) Matrix metalloproteinases in inflammatory bowel disease: boon or a bane? Inflamm. Bowel Dis. 13, 97-107.
31. Kirkegaard, T., Hansen, A., Bruun, E., Brynskov, J. (2004) Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 53, 701-709.
32. Altadill, A., Eiro, N., Gonzalez, L. O., Junquera, S., Gonzalez-Quintana, J. M., Sanchez, M. R., Andicoechea, A., Saro, C., Rodrigo, L., Vizoso, F. J. (2012) Comparative analysis of the expression of metalloproteases and their inhibitors in resected Crohn's disease and complicated diverticular disease. Inflamm. Bowel Dis. 18, 120-130.
33. Hanai, H., Iida, T., Takeuchi, K., Watanabe, F., Yamada, M., Kikuyama, M., Maruyama, Y., Iwaoka, Y., Hirayama, K., Nagata, S., et al. (2008) Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am. J. Gastroenterol. 103, 1210-1216.
34. Yu, J. E., De Ravin, S. S., Uzel, G., Landers, C., Targan, S., Malech, H. L., Holland, S. M., Cao, W., Harpaz, N., Mayer, L., et al. (2011) High levels of Crohn's disease-associated anti-microbial antibodies are present and independent of colitis in chronic granulomatous disease. Clin. Immunol. 138, 14-22.
35. Lichtenstein, G. R., Targan, S. R., Dubinsky, M. C., Rotter, J. I., Barken, D. M., Princen, F., Carroll, S., Brown, M., Stachelski, J., Chuang, E., et al. (2011) Combination of genetic and quantitative serological immune markers are associated with complicated Crohn's disease behavior. Inflamm. Bowel Dis. 17, 2488-2496.
36. Landers, C. J., Cohavy, O., Misra, R., Yang, H., Lin, Y. C., Braun, J., Targan, S. R. (2002) Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto-and microbial antigens. Gastroenterology 123, 689-699.
37. Vermeulen, N., de Beeck, K. O., Vermeire, S., Van, S. K., Michiels, G., Ballet, V., Rutgeerts, P., Bossuyt, X. (2011) Identification of a novel autoantigen in inflammatory bowel disease by protein microarray. Inflamm. Bowel Dis. 17, 1291-1300.
38. Sakiyama, T., Fujita, H., Tsubouchi, H. (2008) Autoantibodies against ubiquitination factor E4A (UBE4A) are associated with severity of Crohn's disease. Inflamm. Bowel Dis. 14, 310-317.
39. Ancuta, P., Moses, A., Gabuzda, D. (2004) Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 209, 11-20.
40. Ancuta, P., Rao, R., Moses, A., Mehle, A., Shaw, S. K., Luscinskas, F. W., Gabuzda, D. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J. Exp. Med. 197, 1701-1707.
41. Von, L. B., Barthel, B., Coupland, S. E., Riecken, E. O., Rosewicz, S. (2000) Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47, 63-73.
42. Legrand, C., Gilles, C., Zahm, J. M., Polette, M., Buisson, A. C., Kaplan, H., Birembaut, P., Tournier, J. M. (1999) Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling. J. Cell Biol. 146, 517-529.
43. Franzè, E., Caruso, R., Stolfi, C., Sarra, M., Cupi, M. L., Caprioli, F., Monteleone, I., Zorzi, F., De, N. D., Colantoni, A., et al. (2013) Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease. PLoS One 8, e69839.
44. Saarialho-Kere, U. K., Vaalamo, M., Puolakkainen, P., Airola, K., Parks, W. C., Karjalainen-Lindsberg, M. L. (1996) Enhanced expression of matrilysin, collagenase, and stromelysin-1 in gastrointestinal ulcers. Am. J. Pathol. 148, 519-526.
45. Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., Lopez-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., Parks, W. C. (1999) Regulation of intestinal α-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286, 113-117.
46. Heinz, A., Taddese, S., Sippl, W., Neubert, R. H., Schmelzer, C. E. (2011) Insights into the degradation of human elastin by matrilysin-1. Biochimie (Paris) 93, 187-194.
47. Busiek, D. F., Baragi, V., Nehring, L. C., Parks, W. C., Welgus, H. G. (1995) Matrilysin expression by human mononuclear phagocytes and its regulation by cytokines and hormones. J. Immunol. 154, 6484-6491.
48. Parks, W. C., Lopez-Boado, Y. S., Wilson, C. L. (2001) Matrilysin in epithelial repair and defense. Chest 120, 36S-41S.
49. Hoeffel, G., Wang, Y., Greter, M., See, P., Teo, P., Malleret, B., Leboeuf, M., Low, D., Oller, G., Almeida, F., et al. (2012) Adult Langerhans cells derive predominantly from embryonic fetal liver monocytes with a minor contribution of yolk sac-derived macrophages. J. Exp. Med. 209, 1167-1181.
50. Schulz, C., Gomez, P. E., Chorro, L., Szabo-Rogers, H., Cagnard, N., Kierdorf, K., Prinz, M., Wu, B., Jacobsen, S. E., Pollard, J. W., et al. (2012) A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86-90.